Chain Drug Review, April 29, 2019
Robust product portfolio comprised of over 150 product families recognized as one of the most extensive in the generic industry Evolving across different categories from typical oral solid products to topicals injectables ophthalmic inhalation and transdermals START VERTICAL INTEGRATION FINISH API FORMULATION MANUFACTURING PACKAGING DISTRIBUTION Quality and value through vertical integration To see our full product portfolio spanning across varied therapeutic categories please visit us at www aurobindousa com product catalog 180
You must have JavaScript enabled to view digital editions.